The sense of hearing depends on a specialized sensory organ in the inner ear, called the cochlea, which contains the auditory hair cells (HCs). Noise trauma, infections, genetic factors, side effects of ototoxic drugs (ie, some antibiotics and chemotherapeutics) or simply aging lead to the loss of HCs and their associated primary neurons. This results in irreversible sensorineural hearing loss (SNHL) as in mammals, including humans; the inner ear lacks the capacity to regenerate HCs and spiral ganglion neurons. SNHL is a major global health problem affecting millions of people worldwide and provides a growing concern in the aging population. To date, treatment options are limited to hearing aids and cochlear implants. A major bottleneck for development of new therapies for SNHL is associated to the lack of human otic cell bioassays. Human induced pluripotent stem cells (hiPSCs) can be induced in 2D and 3D otic cells in vitro models that can generate inner ear progenitors and sensory HCs and could be a promising preclinical platform from which to work toward restoring SNHL. We review the potential applications of hiPSCs in the various biological approaches, including disease modeling, bioengineering, drug testing and autologous stem cell based-cell therapy, that offer opportunities to understand the pathogenic mechanisms of SNHL and identify novel therapeutic strategies. © AlphaMed Press 2021 SIGNIFICANCE STATEMENT: Sensorineural hearing loss is the world's most common sensory deficit and affects nearly 470 million people. Discovery of hiPSCs has allowed the derivation of patient-specific stem cells; they can self-renew and have the capacity to differentiate into otic neurosensory cell derivatives, facilitating the study of disease mechanisms, bioengineering, and stem cell-based cell replacement therapies either as individual cell types or as organoid 3D cultures. We highlight major achievements of, as well as challenges associated with, hiPSC-based otic cell modeling as a human preclinical platform to understand pathogenesis and identify novel therapies.